ACTIVATION OF A CELL-CYCLE-REGULATED HISTONE GENE BY THE ONCOGENIC TRANSCRIPTION FACTOR IRF-2

被引:173
作者
VAUGHAN, PS
AZIZ, F
VANWIJNEN, AJ
WU, SJ
HARADA, H
TANIGUCHI, T
SOPRANO, KJ
STEIN, JL
STEIN, GS
机构
[1] TEMPLE UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,PHILADELPHIA,PA 19140
[2] TEMPLE UNIV,SCH MED,FELS INST CANC RES & MOLEC BIOL,PHILADELPHIA,PA 19140
[3] UNIV TOKYO,FAC MED,DEPT IMMUNOL,BUNKYO KU,TOKYO 113,JAPAN
关键词
D O I
10.1038/377362a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
THE human histone H4 gene FO108 is regulated during the cell cycle with a peak in transcription during early S phase(1,2). The cell-cycle element (CCE) required for H4 histone activation is a sequence of 11 base pairs that binds a protein factor in electrophoretic mobility shift assays that has been designated histone nuclear factor M (HiNF-M)(2,3). Here we report the purification of HiNF-M, and show it to be a protein of relative molecular mass (M(r)) 48K that is identical to interferon (IFN) regulatory factor 2 (IRF-2), a negative transcriptional regulator of the IFN response(4). Recombinant IRF-2 (as well as the related protein IRF-1 (ref. 5)) binds the CCE specifically and activates transcription of this H4 histone gene, IRF-2 has been shown to have oncogenic potential(6), and our results demonstrate a link between IRF-2 and a gene that is functionally coupled to DNA replication and cell-cycle progression at the G1/S phase transition.
引用
收藏
页码:362 / 365
页数:4
相关论文
共 29 条
[1]  
ABDOLLAHI A, 1991, CELL GROWTH DIFFER, V2, P401
[2]  
Ausubel F, 2002, SHORT PROTOCOLS MOL
[3]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[4]   AN INTERFERON GAMMA-REGULATED PROTEIN THAT BINDS THE INTERFERON-INDUCIBLE ENHANCER ELEMENT OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENES [J].
DRIGGERS, PH ;
ENNIST, DL ;
GLEASON, SL ;
MAK, WH ;
MARKS, MS ;
LEVI, BZ ;
FLANAGAN, JR ;
APPELLA, E ;
OZATO, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3743-3747
[5]  
FRAPPIER L, 1991, J BIOL CHEM, V266, P7819
[6]   INDUCTION OF THE TRANSCRIPTION FACTOR IRF-1 AND INTERFERON-BETA MESSENGER-RNAS BY CYTOKINES AND ACTIVATORS OF 2ND-MESSENGER PATHWAYS [J].
FUJITA, T ;
REIS, LFL ;
WATANABE, N ;
KIMURA, Y ;
TANIGUCHI, T ;
VILCEK, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :9936-9940
[7]  
HAHN S, 1992, Current Biology, V2, P152, DOI 10.1016/0960-9822(92)90268-F
[8]   ANTI-ONCOGENIC AND ONCOGENIC POTENTIALS OF INTERFERON REGULATORY FACTOR-I AND FACTOR-II [J].
HARADA, H ;
KITAGAWA, M ;
TANAKA, N ;
YAMAMOTO, H ;
HARADA, K ;
ISHIHARA, M ;
TANIGUCHI, T .
SCIENCE, 1993, 259 (5097) :971-974
[9]  
HARADA H, 1989, CELL, V56, P729
[10]   SEQUENCE OF A CDNA CODING FOR HUMAN IRF-2 [J].
ITOH, S ;
HARADA, H ;
FUJITA, T ;
MIMURA, T ;
TANIGUCHI, T .
NUCLEIC ACIDS RESEARCH, 1989, 17 (20) :8372-8372